Takeda Expands Abroad While Finding Its Way In Its Home Market

TOKYO - Takeda Pharmaceutical Co. Ltd. made a number of moves this week to expand its presence in Europe and China, including licensing Dainippon Sumitomo Co. Ltd.'s antipsychotic agent lurasidone in 26 EU member states and committing to more than triple its sales reps in China by 2015. But in Japan, Takeda and other pharma still grapple with assessing how the Tohoku earthquake has changed the Japanese market